UK Travel Vaccines Market is expected to reach US$ 524.88 Million by 2028

Others Segment to Lead UK Travel Vaccines Market During 2021–2028

According to our latest study on “UK Travel Vaccines Market Forecast to 2028 – COVID-19 Impact and Country Analysis – by Product and Application,” the market is expected to grow from US$ 267.56 million in 2021 to US$ 524.88 million by 2028; it is estimated to grow at a CAGR of 10.1% from 2021 to 2028. The report highlights the major factors driving the market and prominent players with their developments. The growth of the UK travel vaccines market is attributed to increasing travel & tourism and growing incidence of infectious diseases. However, the high cost of travel vaccines is hampering the growth of the UK travel vaccines market.

Initially, the COVID-19 pandemic affected the UK travel vaccine market negatively. The international travel & airplane industry was one of the most affected industries in the UK due to restrictions on international as well as domestic travel by the UK government. The decline in available flights, widespread lockdowns, and dramatic hike in prices of the travel vaccines impeded the supply and shipment plans. This, in turn, led to a massive drop in revenues for many vaccine manufacturing companies, inducing a vicious cycle of a continuous supply shortage. As travel restrictions are being lifted in many countries, the UK tourism industry is remodeling its business; however, the tourism industry is still facing low demand. After the introduction of the COVID-19 vaccine, the UK made it mandatory that a person should be fully vaccinated against COVID-19. Mandatory COVID-19 vaccine policies have been used during the COVID-19 pandemic to increase vaccination rates. Major government authorization bodies such as National Health Service made travel vaccination mandatory, which will support the rise in tourism in the UK and the rise in numbers of tourists and business travelers in the past few years, which suffer from high health risks of ailments has increased the demand for vaccines. Moreover, unprecedented investments by private and public bodies into research and development of vaccines and a rise in infectious diseases will help the market grow.

Based on product, the UK travel vaccines market is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. The others segment held the largest market share in 2021. Moreover, the meningococcal vaccines segment is expected to register the highest CAGR during the forecast period. The others segment primarily includes human papillomavirus (HPV) vaccine, Zika virus vaccine, DPT (tetanus/diphtheria/pertussis), yellow fever, typhoid, Japanese encephalitis, measles, mumps and rubella, rabies, polio, influenza, varicella and shingles, cholera, and others. Typhoid is caused by Salmonella typhi and is common in the UK; ~21.5 million cases are registered every year, with 216,500 deaths every year.  Caused by vibrio cholerae, cholera is an acute diarrheal illness that affects 1.3 to 4 million people and causes 21,000–143,000 deaths yearly in the UK. Vaccines protect against the HPV group of more than 200 related viruses. Out of these, more than 40 spread through direct sexual contact. Two types of HPV can cause genital warts, while more than 24 types can cause certain types of cancers such as cervical, anal, and oropharyngeal. In the US, three HPV vaccines have been licensed for usage – Gardasil, Gardasil 6, and Cervarix. While travel advisories have no recommendations around HPV vaccinations, travelers of all kinds prefer getting vaccinated, especially those who regularly travel to regions with a high prevalence of HPV.

GlaxoSmithKline plc.; Merck & Co., Inc.; Sanofi; Novartis AG; Pfizer Inc.; Dynavax Technologies; Emergent BioSolutions Inc.; Abbott; Seqirus; and Valneva SE are among the leading players operating in the UK travel vaccines market.

UK Travel Vaccines Market, by Product 2021 and 2028 (%)

Based on product, the UK travel vaccines market is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. Based on application, the market is segmented into domestic travel and outbound travel.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com